🔬ResearchSwitching to Subcutaneous Vedolizumab for IBD Maintenance: Real-World Outcomes
A retrospective study indicates that transitioning inflammatory bowel disease patients from intravenous to subcutaneous vedolizumab maintenance therapy is generally safe …

